Site Meter

Explaining fragmentation

You may also like...

6 Responses

  1. Frank Pasquale says:

    Thanks for that very interesting set of proposals. A few thoughts:

    1) On the air travel/health care analogy, Altman et al. had this interesting article in HA a few years ago:

    http://content.healthaffairs.org/cgi/content/full/25/1/11

    “By 2025 the need for general hospitals to cross-subsidize will greatly increase, but their ability to do so will be diminished. U.S. hospitals could begin to resemble U.S. airlines: severely cutting costs, eliminating services, and suffering financial instability.”

    I am pretty surprised that the makers of the video would want to say that airlines should be a model for any industry, let alone health care. Air travel has become one of the most stressful, hated experiences out there. And for someone as tall as me, it’s just not an option in may cases: I can’t fit into a standard coach seat without a lot of discomfort, and I can’t afford first class.

    2) As for the controlled experiment: I really like the idea, but I worry about a “race to the bottom.”

  2. Anup Malani says:

    1) I disagree that airlines should not be a model. They are a fantastic model. Very low death rate (safety). You can reach a ton of places (heterogeneity). Sure, not all people will be happy. But no product does that. And if you don’t like airlines, try cars/car insurance. Fantastic options. Really high and improving quality. Also important is the fact that there is much less waste in those sectors compared to health care.

    2) If race to the bottom leads to bad insurance, we’ll see worse insurance in the free market states. THat’s the point: see what works and what doesn’t. But I am skeptical. I don’t think there is great evidence for race to the top or to the bottom in corp law and we’ve had free markets for corp law for decades. With insurance there is additional risk of adverse selection, but we also have regulatory solutions to address that. Moreover, here may be sufficient risk aversion (or tax benefits) to get even low risk types to insure.

  3. Frank says:

    1) Given Joel Waldfogel’s work in The Tyranny of the Market, I think you’d have to acknowledge that a), at least for someone as tall as I am, the airlines are not a fantastic model, and b), this is a common problem in many markets. You say it’s inevitable that “not all people will be happy,” but that’s a much more significant problem in health care than in, say, soft drinks, leisure trips, or sneakers.

    Any work that tries to apply economic models developed in industries outside the health sector, directly to the health sector, risks missing the unique aspects of the experience of sickness and lack of health. (Ani Satz has suggested these in her contribution to the symposium.) That’s one reason I recommend Geoffrey Hodgson’s work “Towards an alternative economics of health care” to economists who do not focus primarily on health care. As Hodgson states,

    “Leading mainstream health economists suggest that health care has special features that make it different from other domains of application, posing restrictions on the appropriateness of some neoclassical assumptions. . . . [T]he literature points to the presence in health care of externalities, information asymmetries, uncertainty, supplier-induced demand, and derived demand. But while all these features are important, they are neither universal in health care systems nor unique to them.”

    “I try to identify the peculiarities of health care systems by building on the neglected but vital concept of need. By contrast, mainstream economics starts from the subjective satisfaction or utility of the individual. Modern mainstream economics rejects or ignores the concept of need, but many leading economists from Adam Smith to Alfred Marshall have acknowledged objective needs as well as subjective satisfactions.”

    2) “Worse insurance” is “what works” for many large corporate interests.

  4. Anup Malani says:

    1) a) Hetergeneity is a problem when there are scale economies (so centralized producers) and lots of hetergeneity. But less so when there is decentralized production (docs and hospitals). Perhaps health care demands are much more heterogenous, but the problems that most people point to are not about hetergeneity, but mainstream treatments people do not get.

    b) For every Waldfogel book, there are a 10, perhaps 100, articles pointing out how how well markets work or unintended consequences of regulations. Citing Waldfogel or Friedman is not the point. The point is, does more or less competition work in health care and what is the apporpriate level and form of regs. I readily admit that more regs may be the right approach, but I am fairly confident that neither you or I know for sure. I would like to experiment.

    c) This is the most important: even if health markets have flaws, the question is whether governments do better. There are lots of places where they do much worse: post office, defense procurement, prisons, infrastructure maintenance, managing pensions, etc. It is not sufficient to say health care markets have problems, you must show the govt does it better. For some areas, clearly the govt can help, like addressing adverse selection or redistributing wealth so there is an even distribution of health. I am also optimistic about insurance exchanges. But beyond that things get iffy. For example, do we know if government rules against referral fees are better than vertical integration?

    2) Again, that is a closer to cliche than an argument. There is evidence that corps care about the fringe benefits they offer workers: it’s part of the wage competition. Suboptimal insurance (for the worker) yields a lower wage. (Note: I didn’t say less insurance, I said suboptimal.)

  5. Richard Saver says:

    Anup/Frank: I will sidestep the airlines vs. health care debate, but you may be interested to see that others share Frank’s pain

    http://www.cnn.com/2010/TRAVEL/10/14/tall.fliers.rant/index.html?hpt=C2

    To return to Anup’s general comments, I think he aptly points to the problem of how to “transition to … solutions from where we are now.” And I further agree that the Affordable Care Act gets higher marks for coverage and lower marks for fragmentation. There was a degree of path dependence to start with. Plus, a political strategic choice by Democrat leaders to sell health care reform as not really disturbing the status quo for those who already have coverage and are happy with it. While the politics are understandable, this has resulted in a statute that, as Anup observes, has provisions that are not necessarily coordinated and that leaves an awful lot open ended. Because of the statute’s complexity, I am dreading having to teach it for the first time next semester (Anup and others: any teaching tips?) If it is so difficult to even teach, little wonder it has become hard to sell to digruntled voters, even those who stand to benefit from it.

  6. Frank says:

    Thanks for the CNN article, Richard!

    As for the “transition to … solutions from where we are now,” I think we face a pretty stark choice: we can either double down on reinforcing private insurance and private profit motives in a system that is already an outlier in the developed world in terms of its reliance on these kinds of institutions and incentives. Or we can learn more from Europe, Taiwan, etc., as Kieke Okma, Tim Jost, T.R. Reid, Callahan & Wasunna, and others have suggested.

    For me, comparative health policy demonstrates the US system to be wanting, particularly in terms of cost-control, but also in many other dimensions. (Not surprisingly, there are similar deficiencies in broadband internet access in the US compared to many other countries with a more dirigiste approach.)

    I have little doubt that we’ll continue to hear that the market has yet to work its magic; that if only we free it more completely, it can bring us dramatic improvements in cost-control, access, and quality. As long as we have a mixed system, we’ll have endless ideological debates attributing bad outcomes to either market or regulatory forces.

    On a final conciliatory note: I do think that further experiments and pilot programs are important, and I applaud the ACA for setting up many of these. Anup, your point on the referral fee laws is well-taken, and it will be interesting to see how the HHS “Secretary may exercise waiver authority or create new exceptions and safe-harbors related to the physician self-referral law” regarding ACO’s, as this workshop discussed:
    http://www.cms.gov/PhysicianFeeSched/downloads/100510_Meeting_Agenda.pdf

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

*
To prove you're a person (not a spam script), type the security word shown in the picture. Click on the picture to hear an audio file of the word.
Anti-spam image